| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |